Statement of Fresenius Medical Care North America Regarding U.S. Court Ruling Granting Temporary Restraining Order
January 12 2017 - 11:38PM
Business Wire
In response to the U.S. District Court’s ruling today granting a
temporary restraining order regarding charitable contributions for
premium assistance, Fresenius Medical Care North America issued the
following statement:
“Following a hearing earlier today, United States District Judge
Amos L. Mazzant of the Eastern District of Texas has granted a
temporary restraining order (TRO) requested by Dialysis Patients
Citizens (a patient advocacy organization), Fresenius Medical Care,
DaVita, and US Renal, with the support of the American Kidney
Foundation. The TRO request, and the underlying complaint, sought
relief from the Obama administration’s Interim Final Rule (IFR)
that would constrain charitable contributions to the American
Kidney Foundation and similar charitable organizations benefiting
dialysis patients.
The TRO will remain effective until the earlier of January 26,
2017 or the date the court is able to conclude further proceedings
and rule on the plaintiffs’ motion for a preliminary injunction.
Judge Mazzant has scheduled a hearing on the motion for preliminary
injunction in Sherman on January 18, 2017.
We are pleased that the court has issued a temporary restraining
order preventing this improperly issued regulation from going into
effect. Today's ruling will help ensure that Americans with kidney
failure have the same right as every other American to receive
charitable assistance to pay their health insurance premiums. We
look forward to working with the new administration on regulations
that protect the sustainability of the Medicare program while
protecting the ability of Americans to select the health coverage
of their choosing, free from discrimination based on their health
status or disability.”
About Fresenius Medical Care North America
Fresenius Medical Care North America is the premier health care
company focused on providing the highest quality care to people
with renal and other chronic conditions. Through its
industry-leading network of dialysis facilities, outpatient cardiac
and vascular labs, and urgent care centers, as well as the
country’s largest practice of hospitalist and post-acute providers,
Fresenius Medical Care provides coordinated health care services at
pivotal care points for hundreds of thousands of chronically ill
customers throughout the continent. As the world’s largest fully
integrated renal company, it offers specialty pharmacy and
laboratory services, and manufactures and distributes the most
comprehensive line of dialysis equipment, disposable products, and
renal pharmaceuticals. For more information, visit the FMCNA
website at www.fmcna.com. For information about patient services,
visit www.freseniuskidneycare.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170112006166/en/
Fresenius Medical Care North AmericaMediaJon Stone,
781-392-4680Jonathan.d.stone@fmc-na.com
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024